Dapagliflozin genital infection — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Stop dapagliflozin and arrange emergency assessment for possible Fournier’s gangrene
Severe perineal pain or tenderness, swelling and systemic illness in an SGLT2-inhibitor user are warning features of Fournier’s gangrene, a rare necrotising infection. MHRA advice is to stop the SGLT2 inhibitor and urgently start treatment through emergency assessment, including antibiotics and surgical management where required. Treating presumed thrush or delaying review can be catastrophic; Fournier’s gangrene may be preceded by an apparently local urogenital infection.
Reference: MHRA Drug Safety Update: SGLT2 inhibitors and Fournier’s gangrene: https://www.gov.uk/drug-safety-update/sglt2-inhibitors-reports-of-fournier-s-gangrene-necrotising-fasciitis-of-the-genitalia-or-perineum